JP2004501870A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004501870A5 JP2004501870A5 JP2001579823A JP2001579823A JP2004501870A5 JP 2004501870 A5 JP2004501870 A5 JP 2004501870A5 JP 2001579823 A JP2001579823 A JP 2001579823A JP 2001579823 A JP2001579823 A JP 2001579823A JP 2004501870 A5 JP2004501870 A5 JP 2004501870A5
- Authority
- JP
- Japan
- Prior art keywords
- hcl
- antitumor
- composition
- acetate
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/561,917 US6462017B1 (en) | 2000-05-01 | 2000-05-01 | Method of reducing side effects of chemotherapy in cancer patients |
| PCT/US2001/012696 WO2001082949A2 (en) | 2000-05-01 | 2001-04-19 | Method of reducing side effects of chemotherapy in cancer patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004501870A JP2004501870A (ja) | 2004-01-22 |
| JP2004501870A5 true JP2004501870A5 (https=) | 2005-07-07 |
Family
ID=24244042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001579823A Pending JP2004501870A (ja) | 2000-05-01 | 2001-04-19 | ガン患者における化学療法の副作用を軽減させる方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6462017B1 (https=) |
| EP (1) | EP1357935B1 (https=) |
| JP (1) | JP2004501870A (https=) |
| CN (1) | CN100441221C (https=) |
| AT (1) | ATE348630T1 (https=) |
| AU (2) | AU5547501A (https=) |
| CA (1) | CA2407238C (https=) |
| DE (1) | DE60125417D1 (https=) |
| WO (1) | WO2001082949A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072085A1 (en) * | 2001-03-14 | 2002-09-19 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| UA77999C2 (en) * | 2001-12-10 | 2007-02-15 | Thymosin-alpha 1 for treatment of malignant glioblastoma | |
| PL377376A1 (pl) | 2002-11-25 | 2006-02-06 | Sciclone Pharmaceuticals, Inc. | Sposoby ochrony przed uszkodzeniem przez promieniowanie z użyciem Ó-tymozyny |
| JP2006213645A (ja) * | 2005-02-03 | 2006-08-17 | Hokkaido Univ | ゲラニルゲラニルアセトンと抗癌剤とを組み合わせてなる医薬 |
| JP5044150B2 (ja) * | 2005-08-05 | 2012-10-10 | Ｔｏｔｏ株式会社 | 光照射により薬効を消失させる医薬二酸化チタン複合材 |
| US20070292392A1 (en) * | 2006-06-15 | 2007-12-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma |
| US8017129B2 (en) * | 2006-06-15 | 2011-09-13 | SciClone Pharmaceuticals International Ltd | Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma |
| EP2141995B1 (en) * | 2007-03-27 | 2014-11-05 | Perscitus Biosciences, LLC | Compositions and their uses in protecting cells from toxic exposures |
| US20080300166A1 (en) * | 2007-06-01 | 2008-12-04 | Sciclone Pharmaceuticals, Inc. | Treatment of Melanoma with Alpha Thymosin Peptides |
| US20100317583A1 (en) * | 2007-12-14 | 2010-12-16 | Sciclone Pharmaceuticals, Inc. | Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa) |
| CA2753844A1 (en) * | 2008-03-05 | 2009-09-11 | Vicus Therapeutics, Llc | Compositions and methods for mucositis and oncology therapies |
| WO2012109106A1 (en) * | 2011-02-09 | 2012-08-16 | Sciclone Pharmaceuticals, Inc. | Thymosin alpha peptide for preventing, reducing the severity of, and treating infection |
| US20140322320A1 (en) * | 2013-04-24 | 2014-10-30 | Uday Saxena | Novel compositions for emesis control in cancer patients undergoing chemotherapy and methods thereof |
| US10617743B2 (en) | 2014-06-19 | 2020-04-14 | Cls Therapeutics Limited | Method to improve safety and efficacy of anti-cancer therapy |
| WO2016190780A1 (en) | 2015-05-22 | 2016-12-01 | Dmitry Dmitrievich Genkin | Extracellular dna as a therapeutic target in neurodegeneration |
| EP3368064B1 (en) * | 2015-10-29 | 2021-05-19 | CLS Therapeutics Limited | Use of dnase to improve safety and efficacy of anti-cancer chemotherapy |
| CN107137684A (zh) * | 2017-05-23 | 2017-09-08 | 山西中医学院 | 一种用于胃肠疾病的药物组合物及其制备方法和用途 |
| FR3074042A1 (fr) | 2017-11-29 | 2019-05-31 | Galderma Research & Development | Kit pour son utilisation dans la prevention et/ou le traitement des effets secondaires lies a une therapie anticancereuse |
| KR20200122320A (ko) | 2018-01-16 | 2020-10-27 | 씨엘에스 테라퓨틱스 리미티드 | 데옥시리보뉴클레아제 (dnase) 활성을 갖는 효소의 간 발현에 의한 질환의 치료 |
| CN109820859A (zh) * | 2019-04-09 | 2019-05-31 | 上海市计划生育科学研究所 | 醋酸诺美孕酮在制备预防或治疗呕吐或改善恶病质的药物中的应用 |
| IT202300020361A1 (it) | 2023-10-03 | 2025-04-03 | Blue Hydrogen Science S R L | Nuovi utilizzi di soluzioni acquose ad elevata concentrazione di idrogeno |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US527393A (en) * | 1894-10-09 | Busy-test for multiple switchboards | ||
| US5273963A (en) | 1991-03-29 | 1993-12-28 | The George Washington University | Compositions and methods for treating small cell and nonsmall cell lung cancers |
| US5728707A (en) * | 1995-07-21 | 1998-03-17 | Constantia Gruppe | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide |
-
2000
- 2000-05-01 US US09/561,917 patent/US6462017B1/en not_active Expired - Lifetime
-
2001
- 2001-04-19 AU AU5547501A patent/AU5547501A/xx active Pending
- 2001-04-19 EP EP01928641A patent/EP1357935B1/en not_active Expired - Lifetime
- 2001-04-19 JP JP2001579823A patent/JP2004501870A/ja active Pending
- 2001-04-19 CA CA2407238A patent/CA2407238C/en not_active Expired - Fee Related
- 2001-04-19 DE DE60125417T patent/DE60125417D1/de not_active Expired - Lifetime
- 2001-04-19 AT AT01928641T patent/ATE348630T1/de not_active IP Right Cessation
- 2001-04-19 CN CNB018089070A patent/CN100441221C/zh not_active Expired - Lifetime
- 2001-04-19 WO PCT/US2001/012696 patent/WO2001082949A2/en not_active Ceased
- 2001-04-19 AU AU2001255475A patent/AU2001255475B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004501870A5 (https=) | ||
| CA2407238A1 (en) | The use of thymosin alpha 1 to reduce the side effects of chemotherapy in cancer patients | |
| DE69820268T2 (de) | Implantierbare vorrichtung mit einer polymerbeschichtung zur freisetzung von biologisch wirksamen stoffen | |
| CN104818414B (zh) | 一种具有多孔结构的金属植骨材料及其制备和应用 | |
| CN111195374B (zh) | 一种具有骨诱导活性的医用可降解镁-锌-镁复合棒材及其制备方法 | |
| JP2017519753A5 (https=) | ||
| CN109022843B (zh) | 一种医用植入可降解复合棒材及其制备方法 | |
| RU2008117295A (ru) | Новые пиразолопиримидины как ингибиторы циклинзависимых киназ | |
| CA2407371A1 (en) | Quinazoline derivatives for the treatment of tumours | |
| CA2378503A1 (en) | Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation | |
| PE44799A1 (es) | Antagonistas del receptor de vitronectina | |
| CN111155013B (zh) | 一种医用三维打印合金材料及其制备方法 | |
| AU2001255475A2 (en) | Method of reducing side effects of chemotherapy in cancer patients | |
| AU2001255475A1 (en) | Method of reducing side effects of chemotherapy in cancer patients | |
| RU2012104022A (ru) | Способ уменьшения мультилекарственной резистентности с использованием трипирофосфата инозита | |
| JP2023145674A5 (https=) | ||
| JP2005508322A5 (https=) | ||
| Chen et al. | Biodegradable Zinc‐Based Alloys for Guided Bone Regeneration Membranes: Feasibility, Current Status, and Future Prospects | |
| DE3206726A1 (de) | Pharmakadepot | |
| NZ223720A (en) | Dsrna/lymphokine therapy optionally using cyclooxygenase activator to increase the levels of nk (natural killer) and lak (lymphokine activated killer) cells | |
| CN104511051B (zh) | 一种预防和治疗骨感染的复合骨水泥及其制备方法 | |
| De Vos et al. | Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer | |
| US11345981B2 (en) | Biodegradable metal alloy with multiple properties | |
| JPWO2020257429A5 (https=) | ||
| JP2008222506A (ja) | 生物学的活性物質含有リン酸八カルシウム系結晶、その製造方法及びそれを含む医薬組成物 |